Xceed Meets HTX/CIHR Grant Milestone: Decreasing Sample-Prep Time From Days to Less Than E... (array format parallel sample processing ...)

Xceed Meets HTX/CIHR Grant Milestone: Decreasing Sample-Prep Time From Days to Less Than Eight Hours

Date:6/4/2009

array format, parallel sample processing, and analytics to minimize complexity, user interaction, and variability between users and sites.

About htx (www.htx.ca)

The Health Technology Exchange was incorporated in 2004 with one overarching goal - to accelerate the development of the Medical and Assistive Technologies (MAT) cluster in Ontario by helping Ontario-based companies develop and commercialize innovations. Its core programs and services include Research & Development and Commercialization & Market Development, which assists the MAT sector from product evaluation, company creation, and commercialization to international market readiness.

About Xceed Molecular (www.XceedMolecular.com)

Xceed's vision is to advance molecular diagnostics by successfully translating novel multiplex tests into routine clinical practice and to create robust diagnostic solutions to improve disease outcomes. Our products comprise the award-winning Ziplex System for automated gene-expression analysis (available in the US and Canada for research use only), gene-expression services, and pre-configured arrays - Xpress Chips. Xceed is also developing multiplexed genomic tests for the Ziplex platform, both internally and with strategic partners. Xceed's R&D and manufacturing are headquartered in Toronto, Ontario, with executive offices in Wellesley, Massachusetts.

SOURCE Xceed Molecular
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. VirtualScopics Project Balance Exceeds a Record $31 Million
2. Bio-Matrix Scientific Group, Inc. Highlighted in LifeSciencesWorld.com Special Report; Stem Cell Market Projected to Exceed $8 Billion Worldwide by 2016
3. Stallergenes: 2008: Sales Up 16% - Excellent Performance - Guidance Exceeded
4. Oncolytics Biotech Inc.s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study
5. Calorimeters and Thermal Analysis Equipment Market to Exceed $539 Million by 2012, According to New Report by Global Industry Analysts
6. Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts
7. Microplate Instrumentation & Supplies Market to Exceed $5.0 Billion by 2015, According to New Report by Global Industry Analysts, Inc
8. Genetic Testing Market to Exceed $6.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
9. Tishcon Corp Reaches Donation Milestone Exceeds 1 Million Bottles of Multi-Vitamins for Nourish America
10. China Pharma Holdings, Inc. Projects 3rd Quarter 2008 Revenue Growth to Exceed 40%
11. Xceed Ziplex(R) System for Automated Gene-Expression Analysis Wins 2008 R&D 100 Award

Post Your Comments:

(Date:11/20/2009)...CKVILLE, Md., Nov. 20 No...it has priced an underwritten public offering of 6...the public of $3.30 per share. The approximately ...nderwriting discounts and commissions, will be use...ur VLP-based vaccines, internal research and devel...

(Date:11/20/2009)... METTLER TOLEDO recently announced that ..., “The Role of Process Analytical Technology...quo; on December 1, 2009. , ...le of Process Analytical Technology (PAT) in Green...ber 1, Process Analytical Technology (PAT) case st...

(Date:11/19/2009)...VELT, N.Y., Nov. 19 Dr. Mate Hidve...t, responds to a press release issued on November ...ompany for making false and self-serving statement... ,, Dr. Hidvegi stated from his office in Budap...search on Avemar does not apply to AveULTRA, www...

(Date:11/19/2009)...MALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNewswi...ion Resources find that the leading driver of anti... is broad-spectrum activity against gram-positive ... organisms that can cause nosocomial pneumonia, su...rimarily for agents that provide appropriate cover...

Breaking Biology Technology:Novavax Prices Public Offering of Common Stock 2 Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2 American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2 Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2 Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3

[0] Novavax Prices Public Offering of Common Stock [0] Process Analytical Technology (PAT) in Green Chemistry and Green Engineering [0] American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor [0] Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe

...ead NNRTI, RDEA806, and next generation compounds ...ARLSBAD, Calif., Jan. 29 Ardea Biosciences,Inc. (...ata on the Company,s,non-nucleoside reverse transc...uding RDEA806, RDEA427 and RDEA640, will be presen...ses and Opportunistic Infections (CROI) in,Boston,...

... 29 Edwards Lifesciences,Corporation (NYSE: EW )...today announced that it has received conditional a... (FDA) for a revised design to the U.S. pivotal,cl...ortic heart valve,technology. The FDA approved the...tem to the trial, and also granted permission to E...

...ss to Canadian HAI Market; Market Expenditures for... Million by 2012, SUNNYVALE, Calif., Jan. 29 Cep...nada has issued a medical device,license for the X...icillin,Resistant Staphylococcus aureus (MRSA) on ...A test results are available in approximately 70 m...

Other Biology Technology:Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections 2 Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections 3 Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve 2 Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve 3 Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 2 Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 3 Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 4

Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System

(Date:11/19/2009)... A team led by Penn State,s Ross Hardison, T. Min...ogy, has taken a large step toward unraveling how ... products during development and growth. Working w...d Gerd Blobel at Children,s Hospital of Philadelph...ss of producing red blood cells (erythrocytes). Th...

(Date:11/19/2009)... LA JOLLA, CA November 19, 2009 A team led by sc...scovered a direct link between insulina hormone lo...ers such as diabetesand core body temperature. Whi...ce its discovery in the 1920s, this is the first t...tal process of temperature regulation. , The pap...

(Date:11/19/2009)... While most of us would never willingly consume a...asy as plucking sushi from a bento box. New geneti...mparative Genomics at the American Museum of Natur...ated in sushi bars sampled in New York and Colorad...menus was bluefin, and some was even escolar, a wa...

[0] New research into the mechanisms of gene regulation [0] Scripps research scientists find new link between insulin and core body temperature [0] Unknowlingly consuming endangered tuna

...table biomedical devices that can act as artificia...wise paralyzed muscles to be moved might one day b...ence. Writing today in Advanced Materials, Nichola...lleagues describe how they have used hollow, submi...connect an integrated circuit to nerve cells. The ...

... immune response resulting from HIV infection can ... according to a new study appearing in the Oct. 1 ...vailable online. , "Our study demonstrates that HI...resent, next to children and pregnant women, an ad...Pierre Van geertruyden, MD, MSc, lead author of th...

...s at Rensselaer Polytechnic Institute will continu...e with the help of IBM,s Blue Gene supercomputer. ...R) program, this Blue Gene will complement the $10... New York state to create one of the world,s most ..., The equipment will provide a resource for scient...

Other Biology News:Neural networking nanotubes 2 Malaria treatment efficacy compromised in certain HIV-positive patients 2 Supercomputing equipment to advance the frontiers of computational biology 2

Neural networking nanotubes Malaria treatment efficacy compromised in certain HIV-positive patients Supercomputing equipment to advance the frontiers of computational biology

GIBCO Dulbecco's Phosphate-Buffered Saline (D-PBS) (1X) liquid from Invitrogen

(Miller's LB Broth Base) Luria Broth Base powder from Invitrogen

Rat TNF-alpha ELISA Kit, OptEIA from BD Biosciences Pharmingen

LB Broth Base powder (Lennox L Broth Base) from Invitrogen

Biology Products:

GIBCO Dulbecco's Phosphate-Buffered Saline (D-PBS) (1X) liquid from Invitrogen (Miller's LB Broth Base) Luria Broth Base powder from Invitrogen Rat TNF-alpha ELISA Kit, OptEIA from BD Biosciences Pharmingen LB Broth Base powder (Lennox L Broth Base) from Invitrogen

Xceed Meets HTX/CIHR Grant Milestone: Decreasing Sample-Prep Time From Days to Less Than E...(array format parallel sample processing ...)